US LNG exports surge but will buyers in China turn up?
In a recent filing with the U.S. Securities and Exchange Commission (SEC), PolyPid (NASDAQ:PYPD) Ltd., a company specializing in surgical and medical instruments, announced that its chairman, Jacob Harel, will not seek re-election at the upcoming Annual and Extraordinary General Meeting. The meeting is scheduled for June 25, 2025.
Harel, who has served as a director since November 2017 and as chairman of the board since December 2017, will conclude his tenure on the date of the meeting. Shareholders of record as of the close of business on May 27, 2025, will be entitled to notice of and to vote at the meeting.
The filing, a Form 6-K, serves as a report of foreign private issuer pursuant to rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It includes the Notice of Meeting, Proxy Statement, and Proxy Card for the upcoming shareholder event.
Additionally, the Form 6-K report is incorporated by reference into PolyPid Ltd.’s registration statements on Form F-3 and Form S-8, as filed with the SEC, to be a part thereof from the date on which this report is submitted, unless superseded by subsequent documents or reports.
The announcement is part of the company’s regular disclosure requirements and does not suggest any further changes to the company’s management or operations. The information provided is based on the press release statement filed with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.